Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety Study of hMN14 to Treat Either Colorectal or Breast Cancer
This study has been completed.
Study NCT00041652   Information provided by Immunomedics, Inc.
First Received: July 11, 2002   Last Updated: October 21, 2005   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Colorectal Cancer
Colon Cancer
Rectal Cancer
Colorectal Neoplasms
Colorectal Carcinoma
Breast Cancer
Breast Neoplasms
Additional conditions recognized in this trial
Carcinoma
Colonic Neoplasms
Neoplasms
Rectal Neoplasms
More general conditions related to this trial
Breast Diseases
Colonic Diseases
Digestive System Diseases
Digestive System Neoplasms
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Intestinal Diseases
Intestinal Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Glandular and Epithelial
Rectal Diseases
Skin Diseases
Interventions listed in this trial
hMN14 (labetuzumab)
Sponsors listed in this trial
Immunomedics, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services